Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Provides an update on the mechanistic roles of intracellular calcium release channels and their potential as therapeutic targets for heart failure, hypertension, and diabetes.
Ryanodine receptors (RyRs) and inositol 1,4,5‐trisphosphate receptors (IP 3 Rs) are calcium (Ca 2+ ) release channels on the endo/sarcoplasmic reticulum (ER/SR). Here we summarize the latest advances in the field, describing the recently discovered mechanistic roles of intracellular Ca 2+ release channels in the regulation of mitochondrial fitness and endothelial function, providing novel therapeutic options for the treatment of heart failure, hypertension, and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Santulli et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: